Beijing Science Sun Pharmaceutical Co Ltd (300485) — Cash Flow-to-Debt Ratio
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥28.68 Million could theoretically repay 0% of its total liabilities (CN¥171.26 Million) in one year. Explore Beijing Science Sun Pharmaceutical Co Lt long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Beijing Science Sun Pharmaceutical Co Ltd across 14 annual periods. Also explore total assets of Beijing Science Sun Pharmaceutical Co Lt for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Beijing Science Sun Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Beijing Science Sun Pharmaceutical Co Lt worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.82x | CN¥135.97 Million | CN¥166.48 Million | ▲ +495.3% |
| 2023 | 0.14x | CN¥21.21 Million | CN¥154.61 Million | ▼ -80.5% |
| 2022 | 0.70x | CN¥110.43 Million | CN¥157.10 Million | ▼ -54.5% |
| 2021 | 1.55x | CN¥183.30 Million | CN¥118.54 Million | ▼ -17.3% |
| 2020 | 1.87x | CN¥263.73 Million | CN¥141.13 Million | ▲ +2.1% |
| 2019 | 1.83x | CN¥172.52 Million | CN¥94.26 Million | ▲ +156.2% |
| 2018 | 0.71x | CN¥146.52 Million | CN¥205.07 Million | ▼ -11.6% |
| 2017 | 0.81x | CN¥108.21 Million | CN¥133.91 Million | ▼ -55.0% |
| 2016 | 1.79x | CN¥212.89 Million | CN¥118.63 Million | ▼ -34.3% |
| 2015 | 2.73x | CN¥169.36 Million | CN¥62.00 Million | ▼ -8.6% |
| 2014 | 2.99x | CN¥214.23 Million | CN¥71.71 Million | ▼ -28.2% |
| 2013 | 4.16x | CN¥196.82 Million | CN¥47.33 Million | ▼ -3.7% |
| 2012 | 4.32x | CN¥151.93 Million | CN¥35.18 Million | ▲ +81.6% |
| 2011 | 2.38x | CN¥77.06 Million | CN¥32.39 Million | — |